Sionna Therapeutics, Inc. · Brief

Next report

4 days

Nov 4 · before openest.Q3 FY26

Expected move

No implied move.

7 reportsHistory

—≥ implied

Mar 20 '25—0.00%—

May 12 '25—▲+4.71%—

Aug 11 '25—▲+13.36%—

Nov 5 '25—▼−1.57%—

Q1 FY26—▼−7.17%—

May 12 '26±10.9%▼−10.90%×1.00

Q2 FY26—▲+4.80%—

quarterimplied−15%0+15%realized×

Q2 FY26—▲+4.80%—

May '26±10.9%▼−10.90%×1.00

Q1 FY26—▼−7.17%—

Nov '25—▼−1.57%—

Aug '25—▲+13.36%—

May '25—▲+4.71%—

Mar '25—0.00%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 4 report · est.

Bull2 of 3

4disclosed supplier and customer ties in SEC filingsSEC filings

150managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

6 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

0.27%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

SION report session

No linked exposure.

Oct 21impliedImplied move: ±77.3% into Nov 4 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.